1248575

Claire L. Keating, M.D. — FEI 3013753813

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Clinical Investigator (CI)